Peritoneal progression after pancreaticoduodenectomy is a devastating surgical treatment failure: HIPEC gemcitabine is an option.
Citation: Journal of Gastrointestinal Oncology. 12(Suppl 1):S118-S119, 2021 Apr.PMID: 33970167Institution: Washington Cancer InstituteForm of publication: Journal ArticleMedline article type(s): Comment | EditorialSubject headings: IN PROCESS -- NOT YET INDEXEDYear: 2021ISSN:- 2078-6891
Item type | Current library | Collection | Call number | Status | Date due | Barcode |
---|---|---|---|---|---|---|
Journal Article | MedStar Authors Catalog | Article | 33970167 | Available | 33970167 |
English